Abingworth’s Ocugen OCGN Stock Holding History

Abingworth’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,111	Closed	-$16K	–	20
2022 Q2	$16K	Hold	7,111	–	–	0.01%	21
2022 Q1	$23K	Hold	7,111	–	–	0.01%	20
2021 Q4	$32K	Hold	7,111	–	–	0.01%	20
2021 Q3	$51K	Hold	7,111	–	–	0.01%	20
2021 Q2	$57K	Hold	7,111	–	–	0.02%	19
2021 Q1	$48K	Hold	7,111	–	–	0.02%	17
2020 Q4	$13K	Hold	7,111	–	–	﹤0.01%	15
2020 Q3	$2K	Hold	7,111	–	–	﹤0.01%	17
2020 Q2	$2K	Hold	7,111	–	–	﹤0.01%	16
2020 Q1	$2K	Hold	7,111	–	–	﹤0.01%	16
2019 Q4	$4K	Hold	7,111	–	–	﹤0.01%	16
2019 Q3	$20K	Hold	7,111	–	–	0.01%	14
2019 Q2	$84K	Sell	7,111 -22,519	-76%	-$255K	0.03%	14
2019 Q1	$206K	Buy	29,630 +14,815	+100%	+$127K	0.18%	14
2018 Q4	$77K	Hold	14,815	–	–	0.07%	16
2018 Q3	$473K	Hold	14,815	–	–	0.28%	16
2018 Q2	$2.2M	Hold	14,815	–	–	1.26%	14
2018 Q1	$2.44M	Hold	14,815	–	–	1.52%	12
2017 Q4	$1.8M	Hold	14,815	–	–	1.31%	12
2017 Q3	$1.76M	Hold	14,815	–	–	1.22%	15
2017 Q2	$1.58M	Hold	14,815	–	–	1.26%	12
2017 Q1	$1.48M	Hold	14,815	–	–	1.1%	13
2016 Q4	$1.44M	Buy	14,815 +11,867	+403%	+$1.65M	1.2%	11
2016 Q3	$543K	Buy	+2,948	New	+$461K	0.52%	19

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Abingworth's OCGN Position: Q3 2022 in Review

Abingworth sold out of Ocugen (OCGN) in Q3 2022, closing a stake of 7,111 shares — an estimated $16K sold.

Abingworth first reported a position in OCGN in Q3 2016 and held it in 24 quarters. The position peaked at $2.44M in Q1 2018. 128 funds tracked by Wall St. Rank hold OCGN as of Q3 2022.

Abingworth reported no remaining Ocugen position as of Q3 2022 after selling out during the quarter.
Abingworth sold 7,111 Ocugen shares in Q3 2022, an estimated $16K.
Abingworth first reported a position in Ocugen in Q3 2016 and held it in 24 quarters.
Abingworth's Ocugen position peaked at $2.44M in Q1 2018.
128 funds tracked by Wall St. Rank held Ocugen as of Q3 2022.

Based on Abingworth's 13F filing for Q3 2022, filed 10 Nov 2022.